Skip to content

Outpatient Total Knee Arthroscopy (TKA): Comparison of Postoperative Recovery Versus a Conventional Hospitalization

Outpatient Total Knee Prosthesis, Comparison of Postoperative Recovery Versus Conventional Hospitalization: a Retrospective, Single-center, Observational, Comparative Study of Superiority

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07276061
Acronym
PTG
Enrollment
440
Registered
2025-12-10
Start date
2024-03-11
Completion date
2025-12-31
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroscopy

Keywords

knee arthroscopy

Brief summary

Outpatient TKA is a controversial topic due to concerns about its safety as an outpatient procedure, and remains a marginal procedure. Advances in enhanced postoperative rehabilitation protocols, coupled with advances in minimally invasive surgery, have made it possible to operate on an increasing number of patients on an outpatient basis. However, there are no studies in the literature analyzing functional recovery after outpatient TKA in France. The objective of this study was to compare postoperative recovery, assessed by the QoR-15F score, in patients undergoing outpatient TKA compared to those undergoing a conventional hospitalization.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female, 18 years of age or older (no upper age limit) * Undergoing scheduled unilateral total knee replacement surgery between January 1, 2020 and June 30, 2023 at the Strasbourg University Hospitals * Assessed using the QoR-15F score

Exclusion criteria

* Subject who has expressed opposition to the reuse of their data for scientific research purposes. * Revision, emergency, oncological, bilateral, or septic surgery.

Design outcomes

Primary

MeasureTime frame
QoR-15F scoreat Day 1,Day 3, Day 14 and Day 28 post-operative

Countries

France

Contacts

Primary ContactEric NOLL, MD, PhD
eric.noll@chru-strasbourg.fr33 3 88 12 70 76

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026